Campbell, Linda E.

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 2,978

Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome

Schneider, M., Debbané, M., Bassett, A. S., Chow, E. W. C., Fung, W. L. A., van den Bree, M. B. M., Owen, M., Murphy, K. C., Niarchou, M., Kates, W. R., et al. (2014) · American Journal of Psychiatry

Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment

Cited by 779

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity

Kezic, S., O’Regan, G. M., Yau, N., Sandilands, A., Chen, H., Campbell, L. E., Kroboth, K., Watson, R., Rowland, M., Irwin McLean, W. H., et al. (2011) · Allergy

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 295

Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age: Filaggrin mutations, TEWL and eczema at 3 months

Flohr, C., England, K., Radulovic, S., McLean, W. H. I., Campbell, L. E., Barker, J., Perkin, M., & Lack, G. (2010) · British Journal of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 251

RETRACTED: Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year

Kelleher, M., Dunn-Galvin, A., Hourihane, J. O., Murray, D., Campbell, L. E., McLean, W. H. I., & Irvine, A. D. (2015) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 225

Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis

Stain, H. J., Galletly, C. A., Clark, S., Wilson, J., Killen, E. A., Anthes, L., Campbell, L. E., Hanlon, M.-C., & Harvey, C. (2012) · Australian & New Zealand Journal of Psychiatry

Schizophrenia research and treatmentMental Health Treatment and Access

Cited by 178

Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

International 22q11.2 Brain and Behavior Consortium, Davies, R. W., Fiksinski, A. M., Breetvelt, E. J., Williams, N. M., Hooper, S. R., Monfeuga, T., Bassett, A. S., Owen, M. J., Gur, R. E., et al. (2020) · Nature Medicine

Schizophrenia research and treatmentGenomic variations and chromosomal abnormalities

Cited by 139

‘If I don’t Do It, I’m Out of Rhythm and I Can’t Focus As Well’: Positive and Negative Adult Interpretations of Therapies Aimed at ‘Fixing’ Their Restricted and Repetitive Behaviours in Childhood

McCormack, L., Wong, S. W., & Campbell, L. E. (2023) · Journal of Autism and Developmental Disorders

Autism Spectrum Disorder ResearchFamily and Disability Support Research

Cited by 15